Videos / An update on semaglutide for CKD in the presence of T2D
In this Product Explainer, Endocrinologist Prof Richard MacIsaac provides an update on the chronic kidney disease (CKD) indication for semaglutide, explains the PBS criteria and how healthcare professionals can initiate this GLP-1 RA.

Frozen Shoulder – A Practical Guide to Assessment and Management

Implementing the Four Pillars of Heart Failure Management in GP

PCOS Update

Biologics in COPD – 20% of Your Patients Could Benefit

expert
Endocrinologist, Director, St Vincent’s Hospital Melbourne; Professor, University of Melbourne